Background: Cheyne-Stokes respiration with central sleep apnea (CSR-CSA) in congestive heart failure (CHF) is generally considered a poor prognostic indicator, but treatment of CSR-CSA using an adaptive servo-ventilation (ASV) device has been developed. This is the first evaluation of its use in the management of CSR-CSA in Japanese CHF patients. Methods and Results: Four CHF patients with CSR-CSA that was unresponsive to conventional positive airway pressure (CPAP) underwent 3 nights of polysomnography: baseline, CPAP or bi-level PAP, and on the ASV. The apnea-hypopnea index (AHI) and central-AHI (CAHI) were markedly improved on ASV (AHI 62.7±10.1 to 5.9±2.2 /h, p=0.0006, CAHI 54.5±6.7 to 5.6±2.3 /h, p=0.007). In addition, the sleep quality improved significantly on ASV, including arousal index (62.0±10.5 to 18.7±6.2 /h, p=0.012), percentage of slow-wave sleep (2.6±2.6 to 19.4±4.8 %, p=0.042). Conclusions: ASV markedly improved CSR-CSA in patients with CHF. It is a promising treatment for Japanese patients with CHF.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Kasai, T., Narui, K., Dohi, T., Takaya, H., Yanagisawa, N., Dungan, G., … Momomura, S. I. (2006). First experience of using new adaptive servo-ventilation device for Cheyne-Stokes respiration with central sleep apnea among Japanese patients with congestive heart failure - Report of 4 clinical cases. Circulation Journal, 70(9), 1148–1154. https://doi.org/10.1253/circj.70.1148